MedTrace Logo

Sedation for Non-invasive Ventilation in Blunt Chest Trauma

NCT05175781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-07-27

No results posted yet for this study

Summary

Effectiveness of sedation using dexmedetomidine and ketamine to facilitate non-invasive ventilation sessions which improve overall outcome after blunt chest trauma

Conditions

  • Chest Trauma

Interventions

DRUG

Dexmedetomidine Hydrochloride

is a sympatholytic drug that acts as an agonist of α2-adrenergic receptors in certain parts of the brain.

DRUG

Ketamine Hydrochloride

Ketamine is an NMDA receptor antagoni

DRUG

Placebo

Normal saline

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-18
Primary Completion
2022-07-20
Completion
2022-07-26

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05175781 on ClinicalTrials.gov